Heart Disease Risk Score

Not yet recruiting

• Conditions: Unspecified disorder of circulatory system,

• Registration Number: CTRI/2019/07/020471
• Lead Sponsor: Apollo Hospitals

Brief Summary

A Prospective Observational Non-Interventional Study to build a standardized predictive risk score for Indian Population on Cardiovascular risk factors. This is an application program interface which aids in entry of patient’s data related to Cardiovascular risk and predicts the personalized risk score. Total 6100 patients will be included in this study from multiple sites across India. Data elements collected from routinely recorded information in the electronic medical record.Specific laboratory tests or procedures that are mandated as a part of subjects clinical condition are at the discretion of the site investigator under standard practice.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-07-30
• Study Start: 2019-08-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 6100

Inclusion Criteria

Subject presenting for Routine Health Check (Asymptomatic) Subject presenting with Cardiovascular Respiratory General Weakness Abnormal Lab Values or Imaging Tests (Symptomatic) Subject willing to provide informed consent and comply with study procedure.

Exclusion Criteria

Life Threatening Conditions Altered physiological criteria (Triage 1 & 2 of Canadian Triage Acuity Scale) Respiratory Distress (moderate to severe) Trauma Pregnancy or post-partum period Circulatory shock Coma Altered LOC Fever – Sepsis or immuno-compromised patients and Any form of Poisoning Previously treated Coronary Artery Disease with revascularization (PTCA/CABG).

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determining number of cardiovascular events in enrolled subjects who are detected to have high or moderate risks	5 years

Secondary Outcome Measures

Name	Time	Method
Determine the variation of risk score of a subject over a period of time based on recommended risk reduction strategies and medical intervention	5 years

Trial Locations

Locations (5)

All India Institute of Medical Sciences; 🇮🇳 Delhi, DELHI, India

Apollo Gleneagles Hospitals; 🇮🇳 Kolkata, WEST BENGAL, India

Apollo Hospitals; 🇮🇳 Chennai, TAMIL NADU, India

Indraprastha Apollo Hospitals; 🇮🇳 Delhi, DELHI, India

King George Medical University; 🇮🇳 Lucknow, UTTAR PRADESH, India

All India Institute of Medical Sciences

🇮🇳Delhi, DELHI, India

Dr S Ramakrishnan

Principal investigator

9818186179

ramaaiims@gmail.com